Laughlin Whitney M, Chief Legal Officer at AMN Healthcare Services (AMN), has demonstrated a clear selling bias in recent transactions, with $83,101 in total sales outweighing $49,830 in purchases across 23 reported trades. The activity is concentrated exclusively in AMN stock, with all transactions occurring between January 2024 and January 2026. The most significant purchase was a $49,830 acquisition on February 28, 2024, coded as a discretionary transaction (P). However, this was followed by consistent sales, including a $25,076 disposition in October 2025 and multiple smaller sales throughout 2024 and early 2026, such as $20,508 and $4,360 transactions on January 15, 2026.
The pattern shows Laughlin periodically liquidating portions of their AMN holdings, with sales occurring quarterly or more frequently. While the February 2024 purchase suggests a long-term position was established, the subsequent sales—particularly the cluster in January 2026 totaling $26,040—indicate ongoing divestment. The transactions are primarily coded as open-market sales (F), with no recent buys aside from the 2024 acquisition. The dollar values suggest these are meaningful but not block-sized trades, typically ranging from $2,000 to $25,000 per filing. The consistency of sales over two years points to a deliberate reduction in exposure to AMN stock rather than isolated liquidity events.
AI-assisted summary